Bohui Innovation Biotechnology will acquire the Interchim group

Advion Inc. announces parent company Beijing Bohui Innovation Biotechnology Co., Ltd., has filed its intention to acquire Adchim SAS, the parent company of the Interchim group companies. This transaction will subsequently result in the combination of Bohui’s subsidiary Advion Inc., a leader in high performance, small footprint mass spectrometry and Interchim SA, a global provider of chromatography and purification instrumentation and consumables for life sciences, research and industry. Building upon seven years of a successful OEM partnership, the companies’ future elevated multi-national combination for sales of instruments, consumables and customer service is expected to rapidly grow revenue.  The combined suite of solutions will be displayed at global conferences beginning in early March, though each company will sustain direct customer transaction relationships until the subsequent combination.

The boards of both companies have agreed to the transaction, which remains contingent upon regulatory approvals and other customary matters.

Complementing Advion’s strong academic, pharma, biopharmaceutical and clinical position in mass spectrometry and chromatography products, Interchim adds a broad range of flash chromatography, preparative LC systems, SPE, evaporation, chromatography columns and consumables to the company’s combined product portfolio. Partners since 2012, Advion and Interchim led the market by being the first to develop integrated Flash-MS and seamlessly coupling Advion’s high performance expression^® Compact Mass Spectrometer with Interchim’s puriFlash^® chromatography systems. In the future, the combined companies will strengthen the integration and breadth of workflow solutions by adding Advion’s proprietary range of novel sample introduction and assay techniques.